These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis. Mak KK, Ku MS, Lu KH, Sun HL, Lue KH. Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528 [Abstract] [Full Text] [Related]
13. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. Schafer T, Schnoor M, Wagenmann M, Klimek L, Bachert C. Rhinology; 2011 Aug; 49(3):272-280. PubMed ID: 21858255 [Abstract] [Full Text] [Related]
14. Regional deposition of mometasone furoate nasal spray suspension in humans. Shah SA, Berger RL, McDermott J, Gupta P, Monteith D, Connor A, Lin W. Allergy Asthma Proc; 2015 Aug; 36(1):48-57. PubMed ID: 25562556 [Abstract] [Full Text] [Related]
16. Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model. Altuntaş E, Yener G, Doğan R, Aksoy F, Şerif Aydın M, Karataş E. Am J Rhinol Allergy; 2018 May; 32(3):132-138. PubMed ID: 29644886 [Abstract] [Full Text] [Related]
17. Fluticasone furoate: a new intranasal corticosteroid. Kumar R, Kumar D, Parakh A. J Postgrad Med; 2012 May; 58(1):79-83. PubMed ID: 22387656 [Abstract] [Full Text] [Related]